BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 6316799)

  • 1. Laboratory assessment of disappearance patterns of human chorionic gonadotropin from serum of patients with gestational trophoblastic disease.
    Boots LR; Hatch KD; Younger JB
    Ala J Med Sci; 1983 Oct; 20(4):391-4. PubMed ID: 6316799
    [No Abstract]   [Full Text] [Related]  

  • 2. Radioimmunoassay of the beta-subunit of human chorionic gonadotropin, monitor of chemotherapy in gestational trophoblastic neoplasm.
    Jones WB; Lehr M; Lewis JL
    Surg Forum; 1973; 24():563-5. PubMed ID: 4377042
    [No Abstract]   [Full Text] [Related]  

  • 3. [Value of the radioimmunological assay of HCG and its subunits in the diagnosis and follow-up of gestational trophoblastic disease].
    Delpont PJ; Ruf H; Blanc B; Gamerre M; Adrai J; Conte M; Dupont S; Bellia-Rousseau J
    Rev Fr Gynecol Obstet; 1985 Oct; 80(10):737-52. PubMed ID: 2417299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma human chorionic gonadotropin disappearance in hydatidiform mole: a central registry report from the Netherlands.
    Franke HR; Risse EK; Kenemans P; Houx PC; Stolk JG; Vooijs GP
    Obstet Gynecol; 1983 Oct; 62(4):467-73. PubMed ID: 6888825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pregnancy-specific beta-1-glycoprotein in trophoblastic disease.
    Rutanen EM; Seppälä M
    J Clin Endocrinol Metab; 1980 Jan; 50(1):57-61. PubMed ID: 6243133
    [No Abstract]   [Full Text] [Related]  

  • 6. Serum testosterone and dihydrotestosterone in patients with trophoblastic disease.
    Dawood MY; Saxena BB
    Obstet Gynecol; 1976 Jun; 47(6):684-8. PubMed ID: 180465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum levels of macrophage colony-stimulating factor in trophoblastic disease.
    Kohorn EI; Kacinski BM; Stanley ER
    Gynecol Oncol; 2001 Mar; 80(3):383-6. PubMed ID: 11263936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrent gestational trophoblastic disease after hCG normalization following hydatidiform mole in The Netherlands.
    Kerkmeijer LG; Wielsma S; Massuger LF; Sweep FC; Thomas CM
    Gynecol Oncol; 2007 Jul; 106(1):142-6. PubMed ID: 17462723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [HCG and SP1 in serum of patients with hydatidiform mole and chorionepithelioma--relative serum levels of both proteins in correlation to malignancy of the trophoblastic disease].
    Braun P; Leyendecker G
    Arch Gynecol; 1979 Jul; 228(1-4):663-4. PubMed ID: 485549
    [No Abstract]   [Full Text] [Related]  

  • 10. Outcome of pregnancies occurring before completion of human chorionic gonadotropin follow-up in patients with persistent gestational trophoblastic tumor.
    Tuncer ZS; Bernstein MR; Goldstein DP; Berkowitz RS
    Gynecol Oncol; 1999 Jun; 73(3):345-7. PubMed ID: 10366457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of human chorionic gonadotrophin concentrations in the sera of patients with normal and abnormal pregnancy measured by radio-immunoassay and immunoradiometric assay.
    Norman RJ; Buck RH; Joubert SM
    S Afr Med J; 1989 Apr; 75(7):318-9. PubMed ID: 2538933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postevacuation hCG levels and risk of gestational trophoblastic neoplasia in women with complete molar pregnancy.
    Wolfberg AJ; Berkowitz RS; Goldstein DP; Feltmate C; Lieberman E
    Obstet Gynecol; 2006 Mar; 107(3):743. PubMed ID: 16507954
    [No Abstract]   [Full Text] [Related]  

  • 13. Serum progesterone monitoring in post-molar surveillance.
    Vasilev SA; Schlaerth JB; Ahn C; Sauer MV
    Gynecol Oncol; 1994 Sep; 54(3):288-91. PubMed ID: 7522199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New criteria for the diagnosis of gestational trophoblastic disease.
    Romero R; Horgan JG; Kohorn EI; Kadar N; Taylor KJ; Hobbins JC
    Obstet Gynecol; 1985 Oct; 66(4):553-8. PubMed ID: 2995891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of human chorionic gonadotropin regression in molar pregnancies and post-molar nonmetastatic gestational trophoblastic neoplasia.
    Rotmensch J; Rosenshein NB; Block BS
    Gynecol Oncol; 1988 Jan; 29(1):82-6. PubMed ID: 2448190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The serum concentration of specific beta 1-glycoprotein in trophoblastic disease].
    Radikov N
    Akush Ginekol (Sofiia); 1989; 28(2):15-9. PubMed ID: 2548413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent gestational trophoblastic disease after a diploid partial hydatidiform mole coexisting with a normal living fetus.
    Cheung NY; Ngan HY; Ghosh A
    Int J Gynaecol Obstet; 1992 Jul; 38(3):238-9. PubMed ID: 1360430
    [No Abstract]   [Full Text] [Related]  

  • 18. Measurement of human chorionic gonadotropin.
    Goldstein DP; Berkowitz RS; Kosasa TS
    Major Probl Obstet Gynecol; 1982; 14():64-97. PubMed ID: 6273663
    [No Abstract]   [Full Text] [Related]  

  • 19. [Changes in serum human chorionic gonadotropin in patients with hydatidiform mole following evacuation].
    Wang X
    Zhonghua Fu Chan Ke Za Zhi; 1988 Nov; 23(6):362-4, 388. PubMed ID: 2854773
    [No Abstract]   [Full Text] [Related]  

  • 20. Persistent low-level "real" human chorionic gonadotropin: a clinical challenge and a therapeutic dilemma.
    Kohorn EI
    Gynecol Oncol; 2002 May; 85(2):315-20. PubMed ID: 11972394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.